Cholestasis
Gene: FOCAD
Moreno Traspas et al 2022 reported 14 children from ten unrelated families with syndromic form of pediatric liver cirrhosis. Genome/exome sequencing analysis reveled biallelic variants in the FOCAD gene. Most of the mutations were nonsense, frameshift, or splice site alterations, predicted to result in a loss of function, but there were also 3 missense variants at highly conserved residues. Western blot analysis of dermal fibroblasts derived from 2 patients showed near absent FOCAD expression in cellular extracts. There were also decreased levels of the SKIC2 protein, suggesting that FOCAD may contribute to the stability of RNA helicase (OMIM: 619991).
Cholestasis is a feature.
Sources: Expert ReviewCreated: 24 Aug 2022, 5:37 a.m. | Last Modified: 24 Aug 2022, 5:39 a.m.
Panel Version: 0.234
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Liver disease, severe congenital, MIM# 619991
Publications
Gene: focad has been classified as Green List (High Evidence).
Gene: focad has been classified as Green List (High Evidence).
gene: FOCAD was added gene: FOCAD was added to Cholestasis. Sources: Expert Review Mode of inheritance for gene: FOCAD was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: FOCAD were set to 35864190 Phenotypes for gene: FOCAD were set to Liver disease, severe congenital, MIM# 619991 Review for gene: FOCAD was set to GREEN